| Antiviral drug
limits heart disease
When given after a
heart transplant, ganciclovir seems to reduce the risk of heart disease
later on.
References:
Valantine, H.A.,
et al. 1999. Impact of prophylactic immediate posttransplant
ganciclovir on development of transplant atherosclerosis. Circulation
100(July 6):61.
Further Readings:
McDonald, K., et
al. 1989. Association of coronary artery disease in cardiac
transplant recipients with cytomegalovirus infection. American
Journal of Cardiology 64:359.
Sources:
Hannah A.
Valantine
Stanford University School of Medicine
Division of Cardiovascular Medicine
300 Pasteur Drive
Stanford, CA 94305-5246
From Science
News, Vol. 156, No. 6, August 7, 1999, p. 95. Copyright © 1999,
Science Service. |